These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20428079)

  • 21. Chemical constituents from Melicope pteleifolia leaves.
    Nguyen NH; Ha TK; Choi S; Eum S; Lee CH; Bach TT; Chinh VT; Oh WK
    Phytochemistry; 2016 Oct; 130():291-300. PubMed ID: 27374481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the secA gene of Streptomyces lividans encoding a protein translocase which complements and Escherichia coli mutant defective in the ATPase activity of SecA.
    Blanco J; Coque JJ; Martín JF
    Gene; 1996 Oct; 176(1-2):61-5. PubMed ID: 8918233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning of a secA homolog from Streptomyces lividans 1326 and overexpression in both S. lividans and Escherichia coli.
    Gilbert M; Ostiguy S; Kluepfel D; Morosoli R
    Biochim Biophys Acta; 1996 Aug; 1296(1):9-12. PubMed ID: 8765222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkaloids from an endophytic streptomyces sp. YIM66017.
    Zhou H; Yang Y; Zhang J; Peng T; Zhao L; Xu L; Ding Z
    Nat Prod Commun; 2013 Oct; 8(10):1393-6. PubMed ID: 24354182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of small-molecule inhibitors against SecA by structure-based virtual ligand screening.
    De Waelheyns E; Segers K; Sardis MF; Anné J; Nicolaes GA; Economou A
    J Antibiot (Tokyo); 2015 Nov; 68(11):666-73. PubMed ID: 25990955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.
    Tsantrizos YS; Bolger G; Bonneau P; Cameron DR; Goudreau N; Kukolj G; LaPlante SR; Llinàs-Brunet M; Nar H; Lamarre D
    Angew Chem Int Ed Engl; 2003 Mar; 42(12):1356-60. PubMed ID: 12671967
    [No Abstract]   [Full Text] [Related]  

  • 27. A bisamide and four diketopiperazines from a marine-derived Streptomyces sp.
    Li B; Chen G; Bai J; Jing YK; Pei YH
    J Asian Nat Prod Res; 2011 Dec; 13(12):1146-50. PubMed ID: 21985013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a high-throughput screening assay for the discovery of small-molecule SecA inhibitors.
    Segers K; Klaassen H; Economou A; Chaltin P; Anné J
    Anal Biochem; 2011 Jun; 413(2):90-6. PubMed ID: 21338570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of HCV protease inhibitors.
    Chen KX; Njoroge FG
    Curr Opin Investig Drugs; 2009 Aug; 10(8):821-37. PubMed ID: 19649927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactive 2(1H)-Pyrazinones and Diketopiperazine Alkaloids from a Tunicate-Derived Actinomycete Streptomyces sp.
    Shaala LA; Youssef DT; Badr JM; Harakeh SM
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27563872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of the first SecA inhibitors using structure-based virtual screening.
    Li M; Huang YJ; Tai PC; Wang B
    Biochem Biophys Res Commun; 2008 Apr; 368(4):839-45. PubMed ID: 18261984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from Streptomyces sp.
    Kitani S; Yoshida M; Boonlucksanawong O; Panbangred W; Anuegoonpipat A; Kurosu T; Ikuta K; Igarashi Y; Nihira T
    J Antibiot (Tokyo); 2018 Jul; 71(7):662-666. PubMed ID: 29567952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic Bagremycins from Mangrove-Derived Streptomyces sp. Q22.
    Chen L; Chai W; Wang W; Song T; Lian XY; Zhang Z
    J Nat Prod; 2017 May; 80(5):1450-1456. PubMed ID: 28504888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactive Molecules from Mangrove
    Xu D; Tian E; Kong F; Hong K
    Mar Drugs; 2020 May; 18(5):. PubMed ID: 32414163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-influenza virus compound from Streptomyces sp. RI18.
    Takagi M; Motohashi K; Nagai A; Izumikawa M; Tanaka M; Fuse S; Doi T; Iwase K; Kawaguchi A; Nagata K; Takahashi T; Shin-ya K
    Org Lett; 2010 Oct; 12(20):4664-6. PubMed ID: 20843017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel aspartyl protease inhibitors, YF-0200R-A and B.
    Sato T; Nagai K; Shibazaki M; Abe K; Takebayashi Y; Lumanau B; Rantiatmodjo RM
    J Antibiot (Tokyo); 1994 May; 47(5):566-70. PubMed ID: 8040054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salternamides A-D from a Halophilic Streptomyces sp. Actinobacterium.
    Kim SH; Shin Y; Lee SH; Oh KB; Lee SK; Shin J; Oh DC
    J Nat Prod; 2015 Apr; 78(4):836-43. PubMed ID: 25700232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mer-NF5003B, E and F, novel sesquiterpenoids as avian myeloblastosis virus protease inhibitors produced by Stachybotrys sp.
    Kaneto R; Dobashi K; Kojima I; Sakai K; Shibamoto N; Yoshioka T; Nishida H; Okamoto R; Akagawa H; Mizuno S
    J Antibiot (Tokyo); 1994 Jun; 47(6):727-30. PubMed ID: 8040079
    [No Abstract]   [Full Text] [Related]  

  • 39. JBIR-23 and -24, novel anticancer agents from Streptomyces sp. AK-AB27.
    Motohashi K; Hwang JH; Sekido Y; Takagi M; Shin-ya K
    Org Lett; 2009 Jan; 11(2):285-8. PubMed ID: 19086885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical Constituents from Flueggea virosa and the Structural Revision of Dehydrochebulic Acid Trimethyl Ester.
    Chao CH; Lin YJ; Cheng JC; Huang HC; Yeh YJ; Wu TS; Hwang SY; Wu YC
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27649134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.